Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matthew Singleton
Observed name:
Singleton, Matthew
Institution:
QIMR Berghofer Medical Research Institute
Observed institutions:
Translational Research Institute,
The University of Queensland,
QIMR Berghofer Medical Research Institute
ORCID:
0000-0002-7727-2683
Observed ORCID:
0000-0002-7727-2683
OpenAlex ID:
A5103023713
Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
2023
·
Tuan Vo
, Brad Balderson
, et al.
·
Genome Medicine
·
25
PDF
A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype
2023
·
Marija Kojic
, Nour E. H. Abbassi
, et al.
·
Journal of Human Genetics
·
18
PDF
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
2021
·
Laura A. Genovesi
, Amanda Millar
, et al.
·
Genome Medicine
·
14
PDF
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma
2025
·
George L. Joun
, Emma G. Kempe
, et al.
·
Nature Communications
·
13
PDF
Shared molecular regulation of quiescence in neural and glioma stem cells reveals therapeutic vulnerabilities
2026
·
Chandra Choudhury
, Matthew Singleton
, et al.
·
Stem Cell Reports
·
1
PDF
Cnsc-53. Shared Regulation of Quiescence Pathways Between Neural and Glioma Stem Cells Reveals Tgf-β Signalling as a Therapeutic Target in Glioblastoma
2025
·
Chandra Choudhury
, Dana Friess
, et al.
·
Neuro-Oncology
PDF
Investigation into network-defined novel targeted therapies for medulloblastoma
2024
·
Matthew Singleton
Data - Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition.
2023
·
Vo, Tuan
, Balderson, Brad
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
2021
·
Laura Genovesi
, Amanda Millar
, et al.
·
Neuro-Oncology Advances
Show more works
View as search
Works count:
26
Citation count:
71
H-index:
4
I10-index:
4
Year
Topic
Type